General Information of the Compound
Compound ID
CP0536855
Compound Name
US10017502, Example 4b
    Show/Hide
Synonyms
(S)-1 [PMID: 30596500]
1850385-64-6
2-((3S)-7-FLUORO-4-((3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL)-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-YL)-N-METHYLACETAMIDE
2-[(3S)-7-Fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl]-N-methylacetamide
2-[(3~{S})-7-fluoranyl-4-[(3-oxidanylidene-4~{H}-1,4-benzoxazin-6-yl)carbonyl]-2,3-dihydro-1,4-benzoxazin-3-yl]-~{N}-methyl-ethanamide
2-{(3S)-7-Fluoro-4-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-yl}-N-methylacetamide
2H-1,4-Benzoxazine-3-acetamide, 4-((3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl)-7-fluoro-3,4-dihydro-N-methyl-, (3S)-
6C9UKZ0CYE
AC-36749
AKOS040759623
AZD 9977 [WHO-DD]
AZD-9977
AZD9977
Azd 9977
BALCINRENONE
BALCINRENONE [INN]
BDBM238159
CHEMBL3916929
CS-0077469
DB15418
ECV
F82308
GTPL11281
HY-120274
MBKYLPOPYYLTNW-ZDUSSCGKSA-N
MS-26766
SCHEMBL17363859
UNII-6C9UKZ0CYE
US9394291, 4a
    Show/Hide
Structure
Formula
C20H18FN3O5
Molecular Weight
399.378
Canonical SMILES
CNC(=O)C[C@H]1COc2cc(F)ccc2N1C(=O)c1ccc2OCC(=O)Nc2c1
    Show/Hide
InChI
InChI=1S/C20H18FN3O5/c1-22-18(25)8-13-9-28-17-7-12(21)3-4-15(17)24(13)20(27)11-2-5-16-14(6-11)23-19(26)10-29-16/h2-7,13H,8-10H2,1H3,(H,22,25)(H,23,26)/t13-/m0/s1
    Show/Hide
InChIKey
MBKYLPOPYYLTNW-ZDUSSCGKSA-N
CAS
1850385-64-6
Physicochemical Property
logP
1.7005
Rotatable Bonds
3
Heavy Atom Count
29
Polar Areas
96.97
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118599727
ChEMBL ID
CHEMBL3916929
DrugBank ID
DB15418
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01154, Mineralocorticoid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000213 EA.hy 926 Homo sapiens (Human)  2
1
EC50 = 12.59 nM
   TI
   LI
   LO
   TS
2
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 316.23 nM
   TI
   LI
   LO
   TS
CL000952 UAS-MR-bla HEK293 Homo sapiens (Human)  1
1
IC50 = 398.11 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 39.81 nM
Protein ID: PT01631, Mineralocorticoid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 79.43 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( AZD9977 )
Drug Name AZD9977
Company AstraZeneca Wilmington, DE
Indication
Heart failure
Phase 2
Target(s)
Mineralocorticoid receptor (MR)
Modulator